Search

Glaucoma is a common eye condition characterized by the loss of retinal ganglion cells and their axons, optic nerve damage, and visual field defects, which seriously affect a patientʼs quality of life. The pathogenesis of glaucoma is still unclear at present. It presents as damage to retinal ganglion cells, and the main treatment is primarily to reduce intraocular pressure by surgery or taking medication. However, even with well-controlled intraocular pressure, retinal ganglion cells still undergo degeneration, progressive apoptosis, and axonal loss. Therefore, protecting the optic nerve and inhibiting the apoptosis of retinal ganglion cells are the current hot topic for prevention and treatment of glaucoma. Recently, Erigeron breviscapus , originating from Yunnan province in China, has been shown to be a promising herb with neuroprotective effects to treat glaucoma. Therefore, the traditional usage, botanical characteristics, and phytochemical composition of E. breviscapus were explored through a literature review. Furthermore, we have summarized the pharmacological mechanisms of E. breviscapus and its active components in inhibiting the apoptosis of retinal ganglion cells. These research findings can not only provide guidance and recommendations for the protection of retinal ganglion cells but also further explore the potential of E. breviscapus in the treatment of glaucoma. [ABSTRACT FROM AUTHOR]

The future of glaucoma care may lie in the operating room, according to Norbert Pfeiffer, MD, the medical director and Head of Department of Ophthalmology at the University Medical Center of the Johannes Gutenberg University Mainz, Germany. As surgical interventions become more advanced and research findings make recovery easier for patients, glaucoma specialists may shift their approach to surgery. Trends in glaucoma care already show a move towards customized procedures, particularly in microinvasive glaucoma surgery (MIGS). Surgical glaucoma procedures are expected to increase, with a focus on lighter surgeries and the use of devices for real-time intraocular pressure (IOP) measurement and individualized IOP lowering. Additionally, gene and cell therapy may become important aspects of future surgical glaucoma interventions. However, there may be a shortage of surgical glaucoma specialists, highlighting the need for young surgeons to choose glaucoma as a specialty. [Extracted from the article]

Among the study cohort,35 patients (89.7%) had 1 priorcorneal surgery while 4 patients(10.3%) had multiple cornealsurgeries (range: 2 to 7).1 Secondaryopen angle glaucoma was themost common (64.1%), followed bysteroid-induced glaucoma (23.1%). Glaucoma is a leading cause of vision lossworldwide, and the risk of developingglaucoma is known to be higher for patientsundergoing corneal transplant. [Extracted from the article]

This article discusses the growing popularity of handheld tonometers for glaucoma monitoring. The iCare Home2 tonometer allows patients to take pressure readings themselves, providing more data and opportunities to spot patterns. The article also mentions the importance of optometry in glaucoma care and the need for a collaborative approach utilizing the optometric workforce. Technological advancements in tonometry are improving the accuracy and reliability of glaucoma management. Handheld tonometers are gaining popularity due to their ease of use and efficiency. The article concludes by mentioning future advancements in tonometry, such as implantable devices and 24-hour IOP data monitoring. [Extracted from the article]

Lychnophora is a genus of South American flowering plants in the daisy family, popularly known as "Brazilian arnica". It is used in traditional medicine as an anti-inflammatory and analgesic agent, whose active components are derived from chlorogenic acid (CGA) and C-flavonoids. Since the drugs currently used are ineffective to treat glaucoma, agents with antioxidant and anti-inflammatory properties may represent new alternatives in preventing cellular lesions in retinal ischemia. In this study, we report the neuroprotective effects of CGA and 4,5-di- O -[E]-caffeoylquinic (CQA) acid, isolated from Lychnophora plants, in a rodent glaucoma model. Wistar rats were administered intravitreally with 10 µg CGA or CGA, and then subjected to acute retinal ischemia (ISC) by increasing intraocular pressure (IPO) for 45 minutes followed (or not) by 15 minutes of reperfusion (I/R). Qualitative and quantitative analyses of neurodegeneration were performed using hematoxylin-eosin or Fluoro-Jade C staining protocols. All retinas submitted to ISC or I/R exhibited matrix disorganization, pyknotic nuclei, and pronounced vacuolization of the cytoplasm in the ganglion cell layer (GCL) and inner nuclear layer (INL). Pretreatment with CGA or CQA resulted in the protection of the retinal layers against matrix disorganization and a reduction in the number of vacuolized cells and pyknotic nuclei. Also, pretreatment with CGA or CQA resulted in a significant reduction in neuronal death in the GCL, the INL, and the outer nuclear layer (ONL) after ischemic insult. Our study demonstrated that CGA and CQA exhibit neuroprotective activities in retinas subjected to ISC and I/R induced by IPO in Wistar rats. [ABSTRACT FROM AUTHOR]

A case report from Sam Ratulangi University in Manado, Indonesia, discusses the diagnosis and treatment of an 8-year-old boy with orbital rhabdomyosarcoma, a type of cancer affecting skeletal muscle cells. The patient underwent surgical excision of the tumor and was scheduled for chemotherapy. The research emphasizes the importance of early detection and effective intervention in children with swelling, especially in low-resource settings where access to medical tools may be limited. [Extracted from the article]

A patent application titled "Systems And Methods For Applanation Tonometry And Tonography" has been published online by inventors from Cary and Durham, North Carolina. The application describes a handheld, portable, and automated device for measuring intraocular pressure in the eye using fixed force applanation tonometry. This device aims to address the limitations of current methods, such as poor repeatability and the need for expensive equipment, to provide consistent, accurate, and non-invasive measurements crucial for diagnosing and managing eye conditions like glaucoma. [Extracted from the article]

Researchers at the University of Arkansas for Medical Sciences have published a study on lifestyle modifications and environmental risk factors for glaucoma. The study suggests that moderate exercise may help slow the progression of glaucoma, but caution is advised with certain activities like heavy weight-lifting and certain yoga positions. The research also highlights the potential impact of factors such as dietary nitric oxide, smoking intensity, air pollutants, and the inconclusive evidence regarding the use of marijuana in managing glaucoma. Lifestyle and environmental factors are increasingly recognized as significant contributors to glaucoma development and progression, and should be integrated into treatment approaches alongside medications or surgical interventions. [Extracted from the article]

A study conducted at Seoul National University College of Medicine in South Korea examined the impact of choroidal microvasculature dropout (cMvD) on progressive retinal nerve fiber layer (RNFL) thinning in primary open-angle glaucoma (POAG) patients with parapapillary beta-zones and gamma-zones. The research found that the presence of cMvD was significantly associated with a faster rate of RNFL thinning in POAG eyes with beta-zone, but not gamma-zone. This study sheds light on the pathogenic consequences of cMvD in POAG eyes and highlights the importance of considering accompanying peripapillary structures in the disease progression. [Extracted from the article]

A recent study from the Faculty of Medicine in Sibiu, Romania, focused on bilateral idiopathic neuroretinitis, a rare inflammatory condition that causes sudden vision loss. The research described a case of a 33-year-old man with no significant medical history experiencing decreased vision. Despite extensive testing, the exact cause of the condition remained unclear, emphasizing the importance of accurate diagnosis and careful clinical evaluation. This study highlights the need for further research and observation in distinguishing neuroretinitis from other optic nerve disorders. [Extracted from the article]

Researchers at Fudan University in Shanghai, China, have developed ultrathin crystalline silicon-based strain gauges for monitoring soft tissue biomechanics. These strain gauges can track time-dependent mechanics of tissues with deforming surfaces in multiple directions, allowing for dynamic monitoring of strain. The devices have potential applications in monitoring cardiac disorders and hypoxia in living organisms, with the ability to locate pathological orientations associated with specific conditions. The research findings highlight the clinical significance of these devices for monitoring complex dynamic biomechanics. [Extracted from the article]

A patent has been issued for non-invasive and minimally invasive laser surgery to reduce intraocular pressure in the eye, with a focus on treating glaucoma. Glaucoma is a group of diseases that can lead to vision loss or blindness and is a leading cause of irreversible blindness worldwide. Laser surgery techniques such as Argon Laser Trabeculoplasty (ALT) and Selective Laser Trabeculoplasty (SLT) are commonly used to target the trabecular meshwork and increase aqueous humor outflow. The patent details a method and integrated surgical system for reducing intraocular pressure by modifying ocular tissue to reduce pathway resistance in the trabecular meshwork, Schlemm's canal, and collector channels. [Extracted from the article]

A study conducted at the University of Oklahoma investigated the clinical outcomes of canaloplasty, a surgical technique, in patients with primary angle-closure glaucoma. The research found that canaloplasty, either performed alone or in combination with phacoemulsification, effectively reduced intraocular pressure and the number of glaucoma medications required. The study concluded that canaloplasty via an ab-interno surgical technique is a safe and clinically effective treatment for primary angle-closure glaucoma patients up to two years post-operation. [Extracted from the article]

A patent has been issued for a method and device for remote optical monitoring of intraocular pressure by SmartLens Inc. The invention aims to address the need for a device that can accurately measure intraocular pressure throughout the day without interfering with a patient's normal activities. The device, which can be worn as eyewear, includes features such as an illumination source, image sensor, communication portal, and drug dispensing device to provide reliable data for diagnosis and treatment of eye conditions like glaucoma. The patent was filed on July 8, 2021, and published online on October 15, 2024. [Extracted from the article]

A recent study conducted at the University of California San Diego (UCSD) examined the relationship between intraocular pressure (IOP) and the rate of macular vessel density loss in glaucoma patients. The research found that higher IOP levels were associated with faster rates of macular vessel density loss and ganglion cell complex thinning. The study suggests that further research is needed to determine if lowering IOP can reduce microvascular loss in individuals with glaucoma. [Extracted from the article]

A recent report from Siberian State Medical University discusses the pathomorphological changes in the retina associated with chronic intraocular pressure increase in glaucoma. The study emphasizes the importance of analyzing structural, functional, and hemodynamic parameters in diagnosing and treating glaucoma effectively. The research highlights the need for a comprehensive understanding of the mechanisms underlying retinal damage in glaucoma to improve patient care. [Extracted from the article]

The article discusses the impact of elevated intraocular pressure (IOP) on the blood-retinal barrier (BRB) in glaucoma, revealing that compromised BRB integrity may contribute to retinal ganglion cell (RGC) death. The study conducted on mouse models suggests that BRB compromise precedes neurodegeneration and leakage occurs from peripheral veins in the retinal ganglion cell layer. Stabilizing {beta}-catenin in retinal endothelial cells may prevent both vascular leakage and neurodegeneration, indicating a potential therapeutic target for glaucoma treatment. The findings highlight the importance of understanding IOP-induced BRB compromise in glaucoma pathogenesis. [Extracted from the article]

A recent report from the Department of Ophthalmology in Lisbon, Portugal, discusses a case of a 72-year-old patient with decreased visual acuity and ocular discomfort due to a spontaneous filtering bleb. The patient underwent surgical closure of the fistula with transconjunctival sutures and trypan blue staining, resulting in an increase in intraocular pressure and resolution of hypotonic maculopathy. The research highlights the rarity of spontaneous subconjunctival filtering blebs and the successful treatment approach used in this case. For more information, the full article can be accessed for free online. [Extracted from the article]

A recent report from Fudan University discusses the incidence and mechanism of conjunctival chemosis during phacoemulsification in ophthalmology. The study found that intraoperative chemosis is related to the distance from the clear corneal incision to the end of Bowmen's layer, with conjunctival incisions on both sides of the incision effectively preventing chemosis development. The research provides valuable insights into understanding and potentially preventing this complication during eye surgeries. [Extracted from the article]

Researchers at Orenburg State Medical University have highlighted the importance of neuroprotective therapy for glaucoma, emphasizing the need for treatments beyond just controlling intraocular pressure. The study focuses on finding new drugs that can slow down nerve fiber damage in the optic nerve and prevent neuronal death. This literature review discusses recent experimental and clinical studies on promising neuroprotective drugs for glaucoma. For more information, readers can refer to the original article published in the Rossijskij oftal'mologiceskij žurnal. [Extracted from the article]

A recent study from the University of Utah explores the relationship between intraocular pressure (IOP) and glaucoma, emphasizing the importance of monitoring IOP fluctuations for improved patient outcomes. The research highlights advancements in tonometric technologies that have refined our understanding of IOP's role in glaucoma risk and pathogenesis. The study suggests that ambulatory IOP monitoring outside of office hours may provide clinicians with valuable data to enhance glaucoma management and potentially reduce vision loss. Prospective randomized controlled studies are recommended to further investigate the potential benefits of remote tonometry-based glaucoma management. [Extracted from the article]

A study investigated the link between accelerated epigenetic aging and faster glaucoma progression in 100 primary open-angle glaucoma patients with fast progression and 100 with slow progression. Results showed that fast progressors had greater age acceleration compared to slow progressors, indicating a potential association between biological aging and optic nerve damage susceptibility. The study suggests that epigenetic age could serve as a prognostic biomarker for glaucoma progression, with implications for personalized treatment approaches. [Extracted from the article]

A recent report from the University of Utah highlights advancements in the field of glaucoma, emphasizing a shift towards proactive interventions for the disease. The research discusses new diagnostic technologies and techniques, such as home-based intraocular pressure measurement, visual field platforms, and genetic testing, which aim to improve early detection and treatment of glaucoma. These developments have the potential to enhance patient care by enabling a more interventional approach to managing the condition. [Extracted from the article]

Researchers at Oslo University Hospital conducted a study to assess the feasibility of a prototype needle designed to control intraocular pressure during intravitreal injections. The study compared the use of a standard needle with a prototype needle featuring surface grooves to enhance vitreous reflux. Results showed that the prototype needle effectively lowered intraocular pressure, indicating potential for further clinical trials to evaluate its safety and efficacy. This study, published in the International Journal of Retina and Vitreous, provides a proof of concept for a novel needle design in ophthalmology research. [Extracted from the article]

The article from Reactions Weekly discusses the use of the sleeping aid DroomSap, which contains natural ingredients along with the chemical doxylamine. The Netherlands pharmacovigilance centre, Lareb, has received reports of adverse events (AEs) such as palpitations, hallucinations, and dizziness in individuals using DroomSap. Despite the prohibition of selling doxylamine without a prescription in the Netherlands, DroomSap falls under food legislation due to its low dosage of the chemical. [Extracted from the article]

A patent has been issued for surgical instruments designed for anterior goniotomy, a procedure used to treat glaucoma by improving the flow of aqueous humor from the eye and lowering intraocular pressure. The patent, filed by inventors from Dallas and Willowbrook, Illinois, and assigned to RAICO International LLC, describes a micro-surgical instrument with a specifically configured tip to facilitate the procedure. The instrument aims to create a unique cleavage plane below Schwalbe's line to enhance drainage of aqueous humor, ultimately benefiting patients with glaucoma. [Extracted from the article]

A recent study conducted at the All India Institute of Medical Sciences (AIIMS) in New Delhi compared the outcomes of gonioscopy-assisted transluminal trabeculotomy (GATT) and trabeculectomy in patients with advanced pigmentary glaucoma (PG). The research found that GATT alone led to a significant reduction in intraocular pressure and the number of glaucoma medications required for patients with advanced PG. The study concluded that GATT may be a promising treatment option for individuals with this condition, with fewer sight-threatening complications compared to trabeculectomy. [Extracted from the article]

Research from the University of Airlangga in Ophthalmology discusses the management of a painful blind eye with bilateral symblepharon, a challenging condition characterized by ocular discomfort. The case study involves a 38-year-old Indonesian male experiencing vision loss and ocular pain, with treatment focusing on alleviating pain and improving overall well-being. Psychological evaluation and a comprehensive management plan are crucial for successful treatment, aiming to mitigate the adverse impact on the patient's quality of life. The study emphasizes the importance of addressing underlying causes and understanding irreversible visual function loss for patients with symblepharon. [Extracted from the article]

A 6-month-old boy with Adams Oliver syndrome, glaucoma, and anterior polar cataract exhibited lack of efficacy during treatment with brinzolamide and latanoprost. Despite interventions including trabeculectomy and aqueous drainage implants, the boy showed progressive increase in axial length and refractory elevated intraocular pressure. Subsequent treatment with dorzolamide/timolol resulted in improved intraocular pressure control during follow-up visits. [Extracted from the article]

A 67-year-old woman developed bilateral posterior scleritis and bilateral panuveitis after receiving an influenza-virus vaccine. She also experienced lack of efficacy while being treated with bimatoprost for glaucoma. The woman had no prior medical or ocular history and presented symptoms shortly after vaccination, leading to a diagnosis of glaucoma and subsequent treatment. Following a course of prednisone, prednisolone-acetate, and brinzolamide/timolol, she showed improvement in her condition, with resolution of symptoms and improved visual acuity. [Extracted from the article]

A 58-year-old woman developed bilateral subperiosteal orbital hematomas while on aspirin, clopidogrel, and heparin treatment for intracranial aneurysms. The hematomas were diagnosed post-procedure and led to eye pain and vision loss. Despite undergoing canthotomies and receiving medical interventions, the woman experienced persistent vision issues, including blindness in one eye two weeks later. The case highlights the complexities and potential complications of anticoagulant therapy in patients with aneurysms. [Extracted from the article]

Researchers at Shiraz University of Medical Sciences in Iran have conducted a study comparing the biomechanical intraocular pressure (bIOP) measured by the Corvis ST device and the cornea-compensated intraocular pressure (IOPcc) measured by the ocular response analyzer (ORA) before and after photorefractive keratectomy (PRK). The study found that the two devices did not agree well and may not be used interchangeably. The bIOP remained unchanged after PRK, and there was a weak agreement between the Corvis ST-bIOP and the ORA-IOPcc. The researchers suggest that the bIOP may be a better option for IOP reading after PRK. [Extracted from the article]

A recent study conducted by researchers at the Colorado School of Mines has developed a 3D printed model of the human trabecular meshwork (hTM) to study glaucoma. Glaucoma is a progressive eye disease that can lead to irreversible blindness, and elevated intraocular pressure (IOP) is believed to be a factor in its development. The researchers used gelatin methacryloyl bioinks to print the hTM model, which proved to be suitable for printing with viable and proliferative hTM cells. This model could enhance our understanding of cell and tissue behavior in the trabecular meshwork and aid in the development of therapeutic treatments for glaucoma. [Extracted from the article]

An 86-year-old woman with uncontrolled diabetes and end-stage renal disease experienced lack of efficacy during antibiotic therapy for SARS-CoV-2 infection and mucormycosis. Despite treatment with multiple drugs including ceftriaxone, doxycycline, vancomycin, cefepime, metronidazole, remdesivir, steroids, and amphotericin-B-liposomal, her condition worsened. She ultimately passed away due to cardiac arrest, with a post-mortem biopsy confirming invasive fungal sinusitis caused by Rhizopus species. [Extracted from the article]

A new study conducted at the University of Tennessee Health Science Center compared the efficacy of different micropulse laser settings for glaucoma management. The study analyzed data from 351 eyes of patients who underwent micropulse transscleral cyclophotocoagulation (MP-TSCPC) at four power settings. The primary measurements of efficacy were the reduction in intraocular pressure (IOP) and the number of glaucoma medications. The study found that MP-TSCPC at 1500 mW, 2000 mW, and 2500 mW was safe and effective for reducing IOP, while MP-TSCPC at 2250 mW showed delayed effectiveness. No specific power setting was found to be superior in the long term. [Extracted from the article]

A recent study conducted in Karnataka, India, explored the relationship between central corneal thickness (CCT), intraocular pressure (IOP), and optic disc changes in primary open-angle glaucoma (POAG). The researchers aimed to aid in the early detection and management of glaucoma to prevent vision loss. The study found a significant positive correlation between IOP and CCT, indicating that thinner CCT eyes are at a higher risk for advanced disc cupping. The researchers concluded that ophthalmologists should closely monitor patients with thinner corneal readings for possible glaucoma progression. [Extracted from the article]

Researchers from the Centre de Recherche du CHU de Quebec-Universite Laval in Canada have conducted a study on the influence of intraocular pressure on the expression and activity of sodium-potassium pumps in the corneal endothelium. The corneal endothelium plays a crucial role in maintaining corneal transparency by pumping fluid out of the stroma. The study found that physiologic pressure and flow increased the transcription and protein expression of Na+/K+-ATPase a1 in engineered corneal endothelia, while remaining stable in native corneal endothelia. The activity of Na+/K+-ATPase was also increased in the presence of physiologic pressure and flow in both native and engineered corneal endothelia. These findings highlight the importance of the in vivo environment in the functionality of the corneal endothelium. [Extracted from the article]

This article provides information about a newly launched clinical trial, NCT06615661, which focuses on adults with primary open angle glaucoma (POAG) who have undergone goniotomy intraocular pressure (IOP)-lowering surgery with the C-Rex Instrument. The study aims to collect data on IOP, use of glaucoma medications, and device-related complications over a 12-month period. The trial is currently recruiting participants and is expected to be completed by September 2026. The C-Rex Instrument is a manual ophthalmic surgical instrument used for ab interno goniotomy and inner wall trabeculotomy. [Extracted from the article]

A recent study conducted at the University of Freiburg in Germany has found that selective laser trabeculoplasty (SLT) is an effective and cost-effective alternative to eye drop therapy for treating ocular hypertension or open-angle glaucoma. The study analyzed 98 patients who underwent SLT following a previous pressure-reducing procedure. The results showed that approximately 68% of the eyes did not require another pressure-reducing procedure after 365 days, and about 58% remained without another procedure after 730 days. The study concluded that SLT is an effective method for delaying further pressure-reducing interventions in patients. [Extracted from the article]

Microjet Technology Co. Ltd. has been issued a patent for a wearable display device. The device aims to improve the performance and comfortability of wearable displays. It includes a heat dissipation processing module to improve operating efficiency and a micro pump structure to inflate an airbag for comfortable long-term use. Additionally, the device features an intraocular pressure sensor to detect eye strain and provide a warning to avoid excessive use. The patent provides detailed descriptions and claims for the wearable display device. [Extracted from the article]

This document discusses the risks and complications associated with cataract surgery, specifically focusing on the use of high intraocular pressure (IOP) during the procedure. High IOP can cause damage to the cornea, optic nerve, and retina, as well as increase pain for the patient. The document introduces a new technology called Active Fluidics, developed by Alcon Laboratories, Inc., which aims to stabilize IOP and prevent fluctuations during surgery. The document also outlines a research project that will compare the outcomes of phacoemulsification with physiological IOP using Active Fluidics versus traditional high IOP levels. The study is not yet recruiting and is expected to be completed in 2025. [Extracted from the article]

A patent has been issued for devices and methods that address the challenges of fixing macular holes, retinal detachments, and leaking eye wall discontinuities. The inventors have developed devices that can accurately apply a substance, such as a bioadhesive, to damaged tissues, including retinal tissue. These devices can be used for various medical and non-medical applications and are designed to target challenging locations. The patent was filed by Sanulus Medical LLC and is related to cryotherapy and therapeutics in the field of health and medicine. For more information, readers can refer to the provided patent URL. [Extracted from the article]

A study conducted at Chengdu First People's Hospital in China evaluated the efficacy and safety of porcine corneal acellular stromal deep lamellar keratoplasty in the treatment of infectious keratitis. The study included 17 patients who had failed to respond to conservative treatment. The results showed that all patients successfully underwent the procedure without complications, and postoperative corneal infections were effectively controlled. The treatment improved visual acuity and restored corneal anatomy and function. The study suggests that porcine corneal acellular stromal deep lamellar keratoplasty could be a viable alternative to using human corneas in the treatment of infectious keratitis. [Extracted from the article]

A study conducted at Westmead Hospital in Sydney, Australia, has investigated the efficacy of a novel, low-cost glaucoma drainage device in both canine and human patients. The device, constructed by inserting a cannula through adjacent tubes of a surgical drain, showed promising results in maintaining intraocular pressure (IOP) below 20 mm Hg in the majority of eyes at various follow-up periods. However, some eyes required additional procedures or device removal due to complications. The researchers suggest further development of the device, including modifications and preoperative loading of medications. This alternative device has the potential to address the need for glaucoma drainage devices in regions where surgical alternatives are limited. [Extracted from the article]

A recent study conducted by researchers at the Second Clinical Medical College of Jinan University in China focuses on neovascular glaucoma, a type of refractory glaucoma. Neovascular glaucoma is characterized by the formation of neovascularization of the iris and chamber angle, leading to the obstruction of aqueous humor outflow and increased intraocular pressure. This condition can cause severe headache, eye pain, optic nerve damage, and even blindness. The study explores various treatment methods for neovascular glaucoma, such as panretinal photocoagulation, anti-vascular endothelial growth factor, intraocular pressure lowering drugs, and anti-glaucoma surgery. Understanding the pathogenesis and treatment options for neovascular glaucoma is crucial for selecting the most appropriate treatment strategy. [Extracted from the article]

A report from Loma Linda University discusses the potential impact of a vegetarian diet on glaucoma. The researchers note that while the primary treatment for glaucoma focuses on lowering intraocular pressure, there is interest in exploring antioxidant, anti-inflammatory, and neuroprotective strategies. Vegetarian diets are known to be rich in these components and have established health benefits, but their specific effects on glaucoma have not been well studied. The researchers aim to examine the role of vegetarian diets and their components in the incidence and progression of glaucoma. This research has been peer-reviewed and published in the journal Survey of Ophthalmology. [Extracted from the article]

A new report from the Affiliated Hospital of Southwest Medical University in Luzhou, China, explores the potential causal relationship between intraocular pressure (IOP) and myopia. The study included 3,459 patients who underwent corneal refractive surgery between 2021 and 2023. Through rank correlation analysis and Mendelian randomization methods, the researchers found no significant association or causal link between IOP and myopia. These findings challenge the traditional understanding of IOP's role in myopia progression and highlight the complex nature of myopia development. [Extracted from the article]

A new report discusses research findings on keratoconus, a corneal disease. The study aimed to evaluate the diagnostic value of visualized corneal biomechanical analysis combined with Pentacam in diagnosing subclinical keratoconus and forme fruste keratoconus. The researchers enrolled 65 patients with keratoconus and 89 subjects as the normal control group. They used Pentacam combined with Corvis ST for detection and recorded various corneal dilatation indexes and biomechanical indexes. The study found that certain indexes had strong diagnostic ability for different stages of keratoconus, suggesting their potential use for screening and early diagnosis of the disease. [Extracted from the article]